Log in
NYSE:SNN

Smith & Nephew Stock Forecast, Price & News

$39.31
-1.00 (-2.48 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$39.22
Now: $39.31
$40.34
50-Day Range
$39.41
MA: $40.58
$42.13
52-Week Range
$26.07
Now: $39.31
$52.26
Volume720,535 shs
Average Volume657,497 shs
Market Capitalization$17.21 billion
P/E Ratio19.27
Dividend Yield2.23%
Beta0.55
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. Additionally, it offers meniscal repair system. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Read More
Smith & Nephew logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 1.9Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.81 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-19-2347-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.14 billion
Cash Flow$3.11 per share
Book Value$11.76 per share

Profitability

Miscellaneous

Employees17,637
Market Cap$17.21 billion
Next Earnings DateN/A
OptionableOptionable
$39.31
-1.00 (-2.48 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Smith & Nephew (NYSE:SNN) Frequently Asked Questions

How has Smith & Nephew's stock price been impacted by Coronavirus (COVID-19)?

Smith & Nephew's stock was trading at $38.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SNN stock has increased by 1.5% and is now trading at $39.31.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Smith & Nephew?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 2 sell ratings, 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Smith & Nephew
.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) announced its quarterly earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.39 by $0.59.
View Smith & Nephew's earnings history
.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew declared a Semi-Annual dividend on Wednesday, July 29th. Investors of record on Friday, October 2nd will be paid a dividend of $0.278 per share on Wednesday, October 28th. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, October 1st.
View Smith & Nephew's dividend history
.

What price target have analysts set for SNN?

10 brokers have issued 12-month price targets for Smith & Nephew's shares. Their forecasts range from $42.00 to $42.00. On average, they expect Smith & Nephew's stock price to reach $42.00 in the next twelve months. This suggests a possible upside of 6.8% from the stock's current price.
View analysts' price targets for Smith & Nephew
.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a drop in short interest in August. As of August 31st, there was short interest totaling 442,400 shares, a drop of 18.3% from the August 15th total of 541,800 shares. Based on an average trading volume of 438,800 shares, the short-interest ratio is presently 1.0 days. Approximately 0.1% of the company's shares are short sold.
View Smith & Nephew's Short Interest
.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), CVS Health (CVS), Pfizer (PFE), AT&T (T) and Abbott Laboratories (ABT).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Who are Smith & Nephew's major shareholders?

Smith & Nephew's stock is owned by many different retail and institutional investors. Top institutional investors include WCM Investment Management LLC (1.61%), Nuance Investments LLC (1.18%), Cambiar Investors LLC (0.48%), Bank of America Corp DE (0.25%), Envestnet Asset Management Inc. (0.20%) and Goldman Sachs Group Inc. (0.14%).

Which institutional investors are selling Smith & Nephew stock?

SNN stock was sold by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, CIBC Private Wealth Group LLC, US Bancorp DE, Dalton Greiner Hartman Maher & Co., Grantham Mayo Van Otterloo & Co. LLC, Glenmede Trust Co. NA, Todd Asset Management LLC, and Jarislowsky Fraser Ltd.

Which institutional investors are buying Smith & Nephew stock?

SNN stock was purchased by a variety of institutional investors in the last quarter, including Nuance Investments LLC, WCM Investment Management LLC, Goldman Sachs Group Inc., Raymond James & Associates, Neuberger Berman Group LLC, Horizon Investments LLC, Point72 Asset Management L.P., and Bank of America Corp DE.

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $39.31.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $17.21 billion and generates $5.14 billion in revenue each year. The medical equipment provider earns $600 million in net income (profit) each year or $2.04 on an earnings per share basis. Smith & Nephew employs 17,637 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.smith-nephew.com.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The medical equipment provider can be reached via phone at 44-19-2347-7100 or via email at [email protected]

This page was last updated on 9/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.